Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,618
datasets available to search
ShareScore release 0.9.0
Dataset results
1,618 results for “gemcitabine”
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy
ClinicalTrials.gov study NCT02414100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Endostar Continued Pumping Into Vein Combining With Gemcitabine-Carboplatin to Treat Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01549093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00470249. IPD Sharing: NO. Countries: 1. Publications: 0.
Tipifarnib and Gemcitabine Hydrochloride in Treating Women With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00100750. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma
ClinicalTrials.gov study NCT01161186. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00052338. IPD Sharing: Not stated. Countries: 1. Publications: 0.
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
ClinicalTrials.gov study NCT00276003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine in Treating Children With Refractory Solid Tumors
ClinicalTrials.gov study NCT00005577. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
ClinicalTrials.gov study NCT06483555. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC
ClinicalTrials.gov study NCT00452881. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
ClinicalTrials.gov study NCT00082706. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas
ClinicalTrials.gov study NCT01298401. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery
ClinicalTrials.gov study NCT02420847. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer
ClinicalTrials.gov study NCT07310069. IPD Sharing: NO. Countries: 1. Publications: 0.
BAY86-9766 Plus Gemcitabine Phase I Study in Asian
ClinicalTrials.gov study NCT01764828. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
ClinicalTrials.gov study NCT00551122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Patients With Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00142467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01466647. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
ClinicalTrials.gov study NCT00078962. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
ClinicalTrials.gov study NCT00305734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.